234 related articles for article (PubMed ID: 15583821)
1. Neuropeptide-Y and Y-receptors in the autocrine-paracrine regulation of adrenal gland under physiological and pathophysiological conditions (Review).
Spinazzi R; Andreis PG; Nussdorfer GG
Int J Mol Med; 2005 Jan; 15(1):3-13. PubMed ID: 15583821
[TBL] [Abstract][Full Text] [Related]
2. The Roles of Neuropeptide Y in Respiratory Disease Pathogenesis via the Airway Immune Response.
Itano J; Kiura K; Maeda Y; Miyahara N
Acta Med Okayama; 2024 Apr; 78(2):95-106. PubMed ID: 38688827
[TBL] [Abstract][Full Text] [Related]
3. Cross talk about the role of Neuropeptide Y in CNS disorders and diseases.
Bale R; Doshi G
Neuropeptides; 2023 Dec; 102():102388. PubMed ID: 37918268
[TBL] [Abstract][Full Text] [Related]
4. Illuminating the neuropeptide Y
Schüß C; Behr V; Beck-Sickinger AG
Neuropeptides; 2024 Jun; 105():102416. PubMed ID: 38430725
[TBL] [Abstract][Full Text] [Related]
5. Identification of a Suitable Peptidic Molecular Platform for the Development of NPY(Y
Krieger K; Wängler B; Schirrmacher R; Wängler C
ChemMedChem; 2020 Sep; 15(17):1652-1660. PubMed ID: 32681597
[TBL] [Abstract][Full Text] [Related]
6. Neuropeptide Y and its receptors in prostate cancer: associations with cancer invasiveness and perineural spread.
Sigorski D; Wesołowski W; Gruszecka A; Gulczyński J; Zieliński P; Misiukiewicz S; Kitlińska J; Iżycka-Świeszewska E
J Cancer Res Clin Oncol; 2023 Aug; 149(9):5803-5822. PubMed ID: 36583743
[TBL] [Abstract][Full Text] [Related]
7. A D-Y Shaped Neuropeptide Y Mimetic Peptide-Dye Self-Assembly with Maximal Emission Beyond 1300 nm and Glioma Mitochondrial Activity Modulation.
Li Y; He X; Wang P; Yuan B; Pan Y; Hu X; Lu L; Wu A; Li J
Small; 2024 Mar; 20(13):e2308621. PubMed ID: 38109130
[TBL] [Abstract][Full Text] [Related]
8. [
Gleixner J; Gattor AO; Humphrys LJ; Brunner T; Keller M
J Med Chem; 2023 Oct; 66(19):13788-13808. PubMed ID: 37773891
[TBL] [Abstract][Full Text] [Related]
9. The role of NPY signaling pathway in diagnosis, prognosis and treatment of stroke.
Jiang T; Zheng T; Li R; Sun J; Luan X; Wang M
Neuropeptides; 2024 Apr; 104():102412. PubMed ID: 38330680
[TBL] [Abstract][Full Text] [Related]
10. Shuttling of Peptide-Drug Conjugates by G Protein-Coupled Receptors Is Significantly Improved by Pulsed Application.
Ziffert I; Kaiser A; Hoppenz P; Mörl K; Beck-Sickinger AG
ChemMedChem; 2021 Jan; 16(1):164-178. PubMed ID: 32700391
[TBL] [Abstract][Full Text] [Related]
11. Neuropeptide Y nerve paracrine regulation of prostate cancer oncogenesis and therapy resistance.
Ding Y; Lee M; Gao Y; Bu P; Coarfa C; Miles B; Sreekumar A; Creighton CJ; Ayala G
Prostate; 2021 Jan; 81(1):58-71. PubMed ID: 33022812
[TBL] [Abstract][Full Text] [Related]
12. Assessing the quantity of neuropeptide Y in the serum of patients referred to Baqiyatallah Hospital with covid-19 concerning inflammatory factors following steroid therapy.
Mousavi N; Shankayi Z; Bahrami F; Mohammadzadeh T; Alishiri GH; Rezaei MA; Saberi M
Acta Neurol Taiwan; 2024 Dec; 33(4)():175-184. PubMed ID: 38073167
[TBL] [Abstract][Full Text] [Related]
13. Increasing Catecholamine Secretion Through NPY in Pheochromocytomas With False-Negative 123 I-MIBG Scintigraphy.
Ruike Y; Suzuki S; Yokote K
Clin Nucl Med; 2024 May; 49(5):419-426. PubMed ID: 38546331
[TBL] [Abstract][Full Text] [Related]
14. Neuropeptide Y receptors: how to get subtype selectivity.
Pedragosa-Badia X; Stichel J; Beck-Sickinger AG
Front Endocrinol (Lausanne); 2013; 4():5. PubMed ID: 23382728
[TBL] [Abstract][Full Text] [Related]
15. Intricacies of the Molecular Machinery of Catecholamine Biosynthesis and Secretion by Chromaffin Cells of the Normal Adrenal Medulla and in Pheochromocytoma and Paraganglioma.
Berends AMA; Eisenhofer G; Fishbein L; Horst-Schrivers ANAVD; Kema IP; Links TP; Lenders JWM; Kerstens MN
Cancers (Basel); 2019 Aug; 11(8):. PubMed ID: 31390824
[TBL] [Abstract][Full Text] [Related]
16. CREB-B acts as a key mediator of NPF/NO pathway involved in phase-related locomotor plasticity in locusts.
Hou L; Li B; Ding D; Kang L; Wang X
PLoS Genet; 2019 May; 15(5):e1008176. PubMed ID: 31150381
[TBL] [Abstract][Full Text] [Related]
17. DPP-4 Inhibitors as Potential Candidates for Antihypertensive Therapy: Improving Vascular Inflammation and Assisting the Action of Traditional Antihypertensive Drugs.
Zhang J; Chen Q; Zhong J; Liu C; Zheng B; Gong Q
Front Immunol; 2019; 10():1050. PubMed ID: 31134095
[TBL] [Abstract][Full Text] [Related]
18. Purification and Biochemical Characterization of TsMS 3 and TsMS 4: Neuropeptide-Degrading Metallopeptidases in the
Cajado-Carvalho D; da Silva CCF; Kodama RT; Mariano DOC; Pimenta DC; Duzzi B; Kuniyoshi AK; Portaro FV
Toxins (Basel); 2019 Mar; 11(4):. PubMed ID: 30935107
[TBL] [Abstract][Full Text] [Related]
19. What's New in Endocrinology: The Chromaffin Cell.
Eiden LE; Jiang SZ
Front Endocrinol (Lausanne); 2018; 9():711. PubMed ID: 30564193
[TBL] [Abstract][Full Text] [Related]
20. Expression of trophic peptides and their receptors in chromaffin cells and pheochromocytoma.
Thouennon E; Pierre A; Yon L; Anouar Y
Cell Mol Neurobiol; 2010 Nov; 30(8):1383-9. PubMed ID: 21046451
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
